RAPTIVA Pages on BioPortfolio:

Biotechnology News RAPTIVA Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/RAPTIVA-news.htm...

BioPortfolio - Raptiva
Raptiva - BioPortfolio - Indepth. ... Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists
...
http://www.bioportfolio.com/indepth/Raptiva.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio News: BioTrends Research Group, Inc. - Raptiva ...
BioTrends Research Group, Inc. - Raptiva Withdrawal Offers Upside for... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Raptiva_Withdrawal_Offers_U...

BioPortfolio.com - BioWeb AVASTIN BEVACIZUMAB Search
Food and Drug Administration's (FDA) Dermatologic and Ophthalmic Drug Advisory Committee's (DODAC) unanimous recommendation for approval of RAPTIVA® ...
http://www.bioportfolio.co.uk/AVASTIN+BEVACIZUMAB-bioweb.htm...

Wong's BioTech Stock Report - focus on the pipeline Fabrazyme ...
Genentech will co-promote Xolair and Raptiva with Xoma (NASDAQ: XOMA) and Novartis AG ... While the odds of marketing approval looks promising for Raptiva
, ...
http://www.bioportfolio.com/news/biotechsage_6.htm...

Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers
The current leading biologics are Biogen Idec and Genentech's Amevive; Serono, Genentech and XOMA's Raptiva; Wyeth and Amgen's Enbrel and Johnson and ...
http://www.bioportfolio.com/news/datamonitor_115.htm...

BioPortfolio Limited Stakeholder Insight: Psoriasis - Biologics ...
Remicade and Raptiva are the clear favorites at third line 99 ... Raptiva's safety profile continues to signal doom for the brand 114 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_19.html...

The Dermatology Market Outlook to 2013: Competitive landscape ...
The market for psoriasis treatments is forecast to register strong growth between 2008-2013, driven by the performances of key drugs such as Raptiva, ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-Dermatology...

BioPortfolio News: Reportlinker - Reportlinker Adds Monoclonal ...
5.2.4.1 Raptiva (efalizumab). 5.2.5 Asthma. 5.2.5.1 Xolair. 5.2.6 Age-Related Macular Degeneration ... Table 6.10 Global Sales of Raptiva 2003-2006 (US$mn)
...
http://www.bioportfolio.com/news/Reportlinker-Adds-Monoclona...

Results from other life science and pharmaceutical sites:

Genentech: Newsroom: Press Releases: News Release April 8, 2009
8 Apr 2009 ... April 8, 2009 -- Genentech, Inc. announced today a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. ...
http://www.gene.com/gene/news/press-releases/display.do?meth...

FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. ...
8 Apr 2009 ... Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...

RAPTIVA USPI
been observed in patients treated with RAPTIVA (see WARNINGS and .... patients who resumed RAPTIVA treatment upon relapse of psoriasis, 31% (17/55) ...
http://www.gene.com/gene/products/information/pdf/raptiva-pr...

Raptiva (efalizumab) Feb 2009
[UPDATE 04/08/2009] Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Genentech: Investors: Raptiva - Historical Sales
Skip to Content for Raptiva - Historical Sales Menu for Raptiva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/raptiva.ht...

VOLUNTARY U.S. MARKET WITHDRAWAL OF RAPTIVA® (efalizumab)
8 Apr 2009 ... voluntary withdrawal of the psoriasis medication RAPTIVA ... clinical benefit from RAPTIVA, the balance between benefit and risk in the ...
http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformati...

Efalizumab - Wikipedia, the free encyclopedia
Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized
...
http://en.wikipedia.org/wiki/Efalizumab...

Efalizumab (marketed as Raptiva) Information
21 Aug 2009 ... FDA has been informed by Genentech, Inc., the sponsor of Raptiva (efalizumab), of their decision to initiate a voluntary withdrawal of ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...

Definition of Raptiva - NCI Dictionary of Cancer Terms
Raptiva binds to a molecule called LFA-1, and blocks the action of T cells (a type of white blood cell). It is a type of immunosuppressant. ...
http://www.nci.nih.gov/dictionary/?CdrID=589404...

FDA Approves Updated Labeling for Psoriasis Drug Raptiva
16 Oct 2008 ... The US Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.